Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.

PloS one - 1 Jan 2014

Li Chenguang, Hao Ligang, Li Yue, Wang Shengguang, Chen Hui, Zhang Lianmin, Ke Bin, Yin Yuesong, Suo Haijin, Sun Bingsheng, Zhang Bin, Wang Changli

Abstract excerpt

INTRODUCTION: Targeting activating oncogenic driver mutations in lung adenocarcinoma has led to prolonged survival in patients harboring these specific genetic alterations. The prognostic value of these mutations has not yet been elucidated. The prevalence of recently uncovered non-coding somatic mutation in promoter region of TERT gene is also to be validated in lung cancer. The purpose of this study is to show...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 25198510
DOI: 10.1371/journal.pone.0107276
PMCID: PMC4157862

Genes

TERT
EGFR
KRAS
ALK
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.PMID 25198510Read ↗

Recurrent TERT promoter mutations in non-small cell lung cancers.Semantic proximity Read ↗

Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancerSemantic proximity Read ↗

Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.Semantic proximity Read ↗

EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.Semantic proximity Read ↗

Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review).Semantic proximity Read ↗

Molecular subtyping and prognostic assessment based on tumor mutation burden in patients with lung adenocarcinomasSemantic proximity Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.Semantic proximity Read ↗

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsSemantic proximity Read ↗

Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.Semantic proximity Read ↗

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.